Psiquiatria
Nova análise do Global Burden of Disease Study mostra depressão e ansiedade entre as principais causas mundiais de impacto de saúde, além de um aumento significativo decorrente da pandemia de COVID-19.
12 Out, 2021 | 11:24hComunicado de imprensa: New Global Burden of Disease analyses show depression and anxiety among the top causes of health burden worldwide, and a significant increase due to the COVID-19 pandemic – Institute for Health Metrics and Evaluation
Estudo original: Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic – The Lancet
Comentários:
Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns – The Lancet
Covid crisis dramatically worsened global mental health, study finds – The Guardian
Comentário no Twitter (fio – clique para saber mais)
✨🆕–The #COVID19 pandemic led to a stark rise in depressive and anxiety disorders globally in 2020 w/women & younger people most affected, according to a new study by our researchers & collaborators published today in @TheLancet. #GBDstudy #MentalHealth
»https://t.co/qXEDzn3idV pic.twitter.com/4xsofBXyvS
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) October 8, 2021
Dia Mundial da Saúde Mental: priorizar a justiça social, não somente o acesso ao cuidado.
12 Out, 2021 | 11:11hWorld Mental Health Day: prioritise social justice, not only access to care – The Lancet (necessário cadastro gratuito)
Comentário no Twitter
"…under the wrong set of social circumstances, everyone is vulnerable to mental health problems."#WorldMentalHealthDay: prioritise social justice, not only access to care—a Comment by Soumitra Pathare @netshrink and colleagues. https://t.co/AwdSXo8y5H pic.twitter.com/Az6AB9vLmm
— The Lancet (@TheLancet) October 10, 2021
Editorial | Saúde cerebral e seus determinantes sociais.
12 Out, 2021 | 11:10hBrain health and its social determinants – The Lancet
Comentário no Twitter
Globally, action to tackle the social determinants of mental ill health—including poverty, racism, and discrimination—remains a low priority in too many countries.
On #WorldMentalHealthDay, read our Editorial: https://t.co/VRJkZ8kVn5#MentalHealth #WMHD2021 pic.twitter.com/hxvrCoMbt0
— The Lancet (@TheLancet) October 10, 2021
M-A | Acurácia do Questionário sobre Saúde do Paciente-9 para rastreamento e detecção de depressão maior.
12 Out, 2021 | 11:08hVer calculadora: PHQ-9 (Patient Health Questionnaire-9)
Comentário no Twitter
This new study investigates the accuracy of the Patient Health Questionnaire-9 (PHQ-9), the most commonly used depression screening tool in general practice, for detecting major depression https://t.co/9WoI3MofWH
— The BMJ (@bmj_latest) October 10, 2021
Idade de início dos distúrbios mentais pelo mundo: metanálise de grande escala de 192 estudos epidemiológicos.
12 Out, 2021 | 11:06hDiretrizes alemãs para o tratamento de distúrbios de ansiedade.
8 Out, 2021 | 12:17hEstudo mostra que dizer “pessoa com esquizofrenia”, em vez de “esquizofrênico”, pode ser mais adequado e impactar o tratamento médico.
1 Out, 2021 | 21:44hArtigo original: It’s Time for Counselors to Modify Our Language: It Matters When We Call Our Clients Schizophrenics Versus People With Schizophrenia – Journal of Counseling & Development ($)
Estudo randomizado | Manutenção vs. descontinuação de antidepressivos em pacientes que se sentem bem o suficiente para suspender a terapia antidepressiva.
1 Out, 2021 | 20:18hMaintenance or Discontinuation of Antidepressants in Primary Care – New England Journal of Medicine
Comentários:
Many can stop anti-depressants without relapse – BBC
Study highlights difficulty of stopping antidepressants – Associated Press
Revisão | Metilfenidato para transtorno de déficit de atenção/hiperatividade em adultos.
1 Out, 2021 | 20:07h
Comentário no Twitter
Review: Methylphenidate is effective both against the core ADHD symptoms (SMD=0.49; 0.35–0.64), and the emotion regulation deficits (SMD=0.34; 0.23–0.45) in adults with ADHD. Long-term AEs: decreased appetite, dry mouth, heart palpitations, agitation https://t.co/V73jPK58pL
— PfOL (@psychopharmacol) September 25, 2021
M-A | Magnitude da resposta ao placebo entre as modalidades de tratamento usadas para a depressão resistente em adultos.
1 Out, 2021 | 19:14hComentário convidado: Treatment-Resistant Depression—Resistant to Placebos as Well? – JAMA Network Open
Comentário no Twitter
This systematic review and meta-analysis found that in studies of patients with treatment-resistant depression, the placebo effect was large and consistent despite the modality use. https://t.co/U6efJo7rJ8
— JAMA Network Open (@JAMANetworkOpen) September 24, 2021
Important systematic review study: The placebo effect in clinical trials of depression, even if treatment-resistant, is huge!
Magnitude of the Placebo Response Across Treatment-Resistant Depression in Adults https://t.co/ey2hIpE61r via @JAMANetworkOpen part of @JAMANetwork
— Yasser Ad-Dab'bagh (@yasseraddabbagh) September 25, 2021
Question
Why does research on 'treatment resistance' have such high placebo response?3 Answers
1)Research patients arent nearly as sick as patients in clinical practice
2)Research patients get much more attention than clinical patients
3)Research raises very high expectations https://t.co/f8CyTpKofV— Allen Frances (@AllenFrancesMD) September 26, 2021
(fio – clique para saber mais)
The paradox of "treatment resistance" in psychiatry that doesn't seem to generate much discussion: if the depression is so treatment resistant that we are considering things like invasive brain stimulation, how come it responds to "placebo" so robustly?/1https://t.co/oQOBPXtVXO
— Awais Aftab (@awaisaftab) September 26, 2021